X 57, MIDC, Kudal,
Sindhudurg, Maharashtra – 416520
Call Us
+91 8080485895
+91 7588783924
Hemophilia Care
Hemophilia is a chronic, hereditary bleeding disorder that affects the body’s ability to form blood clots. This rare condition is caused by a deficiency or absence of certain clotting factors—specifically Factor VIII in Hemophilia A and Factor IX in Hemophilia B.
Hemophilia Care
Overview of Hemophilia
Hemophilia is a chronic, hereditary bleeding disorder that affects the body’s ability to form blood clots. This rare condition is caused by a deficiency or absence of certain clotting factors—specifically Factor VIII in Hemophilia A and Factor IX in Hemophilia B. These clotting proteins are essential for blood to coagulate properly, and without them, even minor injuries can result in prolonged or spontaneous bleeding episodes.
Hemophilia is primarily an inherited condition passed down through the X chromosome, which explains why it predominantly affects males, although females can be carriers. However, up to one-third of cases occur due to spontaneous genetic mutations, even in families without a prior history of the disorder.
At Konkan Cancer Center, our multidisciplinary team understands the physical, emotional, and social impact of living with hemophilia. We offer expert diagnostics, compassionate care, and comprehensive treatment programs tailored to individual needs. From children diagnosed early to adults managing long-term symptoms, Konkan Cancer Center is equipped with advanced technologies and specialists to help patients live safer, healthier lives.
Signs & Symptoms
The symptoms of hemophilia may vary depending on the severity of the condition. While individuals with mild hemophilia may not notice symptoms until surgery or trauma occurs, those with moderate to severe forms often experience spontaneous bleeding episodes that can be life-threatening if untreated.
Common signs and symptoms of hemophilia include:
Excessive bleeding from cuts or injuries that lasts longer than expected.
Spontaneous bleeding into joints, muscles, or soft tissues without any trauma.
Pain, swelling, and limited range of motion due to joint bleeds.
Unexplained bruises or large hematomas, even from minor bumps.
Frequent and prolonged nosebleeds without a clear cause.
Blood in the urine (hematuria) or stools (melena), indicating internal bleeding.
Excessive bleeding after vaccinations, dental procedures, or surgeries.
Recognizing these symptoms early can lead to faster diagnosis and better management. At Konkan Cancer Center, we encourage individuals and families with a known history of bleeding disorders to undergo early screening and consultation with our hematology specialists.
When to See a Hematologist
Prompt consultation with a hematologist is crucial if you or your child shows signs of frequent or unexplained bleeding. Early diagnosis and ongoing monitoring by a specialist can prevent complications such as joint deformities, anemia, and life-threatening bleeds.
You should consult a hematologist at Konkan Cancer Centre if:
There is a family history of hemophilia or bleeding disorders.
Your child experiences joint swelling, unexplained bruising, or spontaneous bleeding.
You’ve had complications following surgery or dental procedures due to excessive bleeding.
You notice blood in urine, stool, or frequent nosebleeds.
Konkan Cancer Center’s expert team offers individualized care plans, genetic counseling, and emergency support for patients with bleeding disorders.
+91 8080485895
+91 7588783924
Diagnostic Tests & Procedures
At Konkan Cancer Centre, we utilize a wide range of advanced blood tests to confirm hemophilia and assess its severity. The diagnostic journey begins with:
Complete Blood Count (CBC): To rule out other blood-related conditions.
Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT): These tests measure how long it takes your blood to clot and can indicate deficiencies in clotting factors.
Clotting Factor Assays: The gold standard test for diagnosing hemophilia, this test measures the levels of Factor VIII or IX directly to determine the type and severity.
Genetic Testing: Identifies specific mutations in the F8 or F9 genes responsible for Hemophilia A or B. This is especially important for family counseling and early intervention.
These results are interpreted in the context of clinical symptoms, family history, and bleeding patterns to ensure accurate diagnosis and optimal care.
Treatment Options for Hemophilia
Konkan Cancer Centre offers a full spectrum of treatments tailored to the patient’s condition and lifestyle. The cornerstone of hemophilia management is clotting factor replacement therapy, which involves injecting the missing clotting factors into the bloodstream.
Two main types of clotting factor concentrates are used:
Plasma-derived concentrates from donated blood.
Recombinant concentrates, created through genetic engineering, which are safer and more commonly used.
Other therapies include:
Desmopressin (DDAVP): Stimulates the body to release stored Factor VIII in mild Hemophilia A.
Antifibrinolytic medications: Help stabilize blood clots.
Emicizumab: A monoclonal antibody for patients with Hemophilia A, especially those with inhibitors.
Gene therapy (emerging): Promising long-term treatment that targets the underlying genetic mutation.
For those with severe joint damage, orthopedic surgeries may be recommended. At Konkan Cancer Center, patients receive not only medical treatment but also access to physiotherapy, nutritional counseling, and psychosocial support.
Gold Standard Treatment
The gold standard for managing hemophilia is prophylactic clotting factor replacement therapy. Administered on a regular basis, this therapy prevents spontaneous bleeding, protects joints, and improves overall quality of life.
This preventative approach, guided by specialists at Konkan Cancer Center, is customized based on age, activity level, and individual needs. We also provide home infusion training, making it easier for patients to manage their condition independently.
Prognosis & Long-Term Care
With proper treatment, individuals with hemophilia can live full, active lives. Modern therapies have significantly improved the outlook for hemophilia patients, reducing hospitalizations and long-term disability.
Regular follow-ups at Konkan Cancer Center ensure:
Monitoring for inhibitor development.
Managing complications like joint damage.
Adjusting treatment plans based on lifestyle or health changes.
Access to emergency intervention protocols for major bleeds.
Our hemophilia clinic also provides genetic counseling for families and educational programs to empower patients with the knowledge they need to manage their condition.
Most Asked FAQs on Thyroid Cancer at a Glance
Unexplained bruising, joint swelling, and prolonged bleeding from minor injuries are common early indicators.
While rare, females can have hemophilia if they inherit two defective X chromosomes. Most are carriers but may experience symptoms.
There is currently no cure, but ongoing gene therapy trials offer hope for a potential long-term solution.
Yes. With proper treatment and precautions, most people with hemophilia can live active and fulfilling lives.
Avoid contact sports, always carry medical identification, keep clotting factor on hand, and maintain regular follow-ups with your hematologist.
Consult the Experts at Konkan Cancer Center
If you or a loved one is affected by hemophilia, the Hematology Unit at Konkan Cancer Centre is here to help. From advanced diagnostics and expert treatments to lifelong care, we provide a comprehensive approach to managing hemophilia.
